Overview
Tiphanie Bouchez practices practicing medicine in Nice, France.
Her clinical expertise encompasses Severe Acute Respiratory Syndrome (SARS) and COVID-19.
She is actively involved in clinical research, co-authoring 14 peer reviewed articles and participating in 1 clinical trial.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Frequently Asked Questions about Tiphanie Bouchez
Is Tiphanie Bouchez a top-rated expert for Severe Acute Respiratory Syndrome (SARS)?
MediFind is an objective health platform that identifies experts based on real-world data. Tiphanie Bouchez is classified as an Experienced expert for Severe Acute Respiratory Syndrome (SARS), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Tiphanie Bouchez participate in research or clinical trials?
Yes. Tiphanie Bouchez has published 14 articles and abstracts on conditions like Severe Acute Respiratory Syndrome (SARS). You can view a list of Tiphanie Bouchez's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- COVID-19Ms. Bouchez isExperienced. Learn about COVID-19.
- Severe Acute Respiratory Syndrome (SARS)Ms. Bouchez isExperienced. Learn about Severe Acute Respiratory Syndrome (SARS).